On 11 February, Bella Aurora reaffirmed its commitment to the visibility and promotion of female talent in science in celebration of the International Day of Women and Girls in Science.

On its 135th anniversary, Bella Aurora Labs consolidates its position as a leading laboratory in skin pigmentation thanks to the fundamental research it carries out, which enables the development of effective solutions for hypopigmented and hyperpigmented skin.

Bella Aurora celebrates its 135th anniversary with the exhibition “Bella Aurora: a legacy of 135 years”. An exciting virtual journey from 1890 to the present day.

The American journal Medicine, specialising in research articles on medical scientific disciplines and subspecialties, has recently published the clinical case of Repigment12. 

Bella Aurora continues with its international expansion plan with the opening of its new subsidiary in Brazil, the third of the company in the American continent. 

The Institute for Ethics in Communication and Organizations (IECO) of the University of Valencia has published the Decalogue of Good Practices in Humanistic Leadership and is the result of the work between academics and company executives, among which is Bella Aurora Labs. 

 

Recently, Bella Aurora has equipped its Customer Care and CRM teams with new technological tools that allow them to provide a better response to all their customers, and Microsoft has highlighted the project in question and considers it a success story. 

In May 2021 Cinzia Pavan decided to try Repigment12 and in just 35 days of treatment she saw how her skin began to regain its colour and she, her smile.

After 4 years of work alongside Dr. Matteo Bordignon, an Italian dermatologist specialising in the study of vitiligo, Bella Aurora, with more than 130 years of experience in the study of melanocytes, presents Repigment, its first effective treatment for white spots.